Happy 2022 and everything goes well

News 2021.12.315170

Related News

Neuboron's NeuPex AB-BNCT System Approved for the "Green Channel" Special Review Process by the NMPA to Drive Commercialization for a Novel Targeted Radiotherapy Modality

2023.08.15
Neuboron Pioneers BNCT Technology Advancement and Drives Novel Boron Drug Transformation through Academic-Industry Collaboration

2023.12.13
Rainer Gunzelmann, Partner of Wuesthoff & Wuesthoff，presides as the honorary international chief IP consultant of Neuboron Medtech since 2021

2021.03.19
The 2nd International BNCT Development Forum Is Delayed

2020.05.27